NeuroOne Medical Technologies Overview

NeuroOne Medical Technologies Research & Development

Research & Development expenses for NMTC.

Quarterly R&D Expenses

$1.47M

↓ 2.82% YoY

As of Mar 31, 2026

Annual R&D Expenses (TTM)

$5.16M

↑ 3.35% YoY

Trailing 12 months ending Mar 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin